Biotics Research Plans Rosenberg, Texas, Headquarters-Research Center
07/15/2021
Anticipated to be complete in 2023, the 87,569 square feet new facility will be built in the Rosenberg Business Park. Biotics Research, which has been in Rosenberg for nearly 25 years, will retain their existing manufacturing building.
“Biotics Research is a valued member of the Rosenberg business community, and we are thrilled to work with them and congratulate them on their expansion to the 184-acre deed restricted Rosenberg Business Park,” said Rosenberg Mayor Kevin Raines. “The Business Park was developed not only to attract new businesses to our city, but to retain and create opportunities for existing businesses such as Biotics Research.”
According to Fort Bend County, Biotics Research is one of the City of Rosenberg’s largest employers and will be one of the first to build in the city’s deed restricted Business Park. A family-owned business, Biotics Research has grown and expanded since it was incorporated in 1976.
Project Announcements
ValorFlex Packaging Plans Bowling Green, Kentucky, Production Operations
06/30/2025
Neuro.io Plans Terrebonne Parish, Louisiana, Operations
06/30/2025
Germany-Based MTU Maintenance Expands Fort Worth, Texas, MRO Operations
06/30/2025
Cascade Die Casting Group Expands High Point, North Carolina, Manufacturing Operations
06/30/2025
BuildOps Plans Raleigh, North Carolina, Operations
06/30/2025
Point Blank Enterprises Plans Wakulla County, Florida, Operations
06/30/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
From Silicon to Server: Mapping the Data Center Supply Chain
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024